Advertisement
Loading...

Translational Development Acquisition Corp.

TDACU•NASDAQ
Financial Services
Shell Companies
$17.29
$6.89(66.25%)
U.S. Market opens in 7h 50m
Advertisement

Translational Development Acquisition Corp. (TDACU) Stock Overview

Explore Translational Development Acquisition Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap362.3M
P/E Ratio29.57
EPS (TTM)$-0.71
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$10.45
3 Months$10.48
1 Year Target$10.22

TDACU Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Translational Development Acquisition Corp. (TDACU) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $10.22.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.57 and a market capitalization of 362.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
41.44%
5-Day Change
40.90%
1-Month Change
40.90%
3-Month Change
40.90%
6-Month Change
40.90%
Year-to-Date (YTD) Change
40.90%
1-Year Change
41.99%
3-Year Change
46.95%
5-Year Change
46.95%
All-Time (Max) Change
46.95%

Contact Information

http://www.tridentacquisitions.com
646 229 7549
77 Water Street, New York City, NY, 10006

Company Facts

20 Employees
IPO DateDec 23, 2024
CountryUS

Frequently Asked Questions